Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The gross margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly gross margin; no daily interpolation. Q4 FY2026 (2026-06-30): 0.00%.
GROSS MARGIN
0.00%
GROSS MARGIN AVG TTM
0.00%
GROSS MARGIN AVG 3Y
N/A
GROSS MARGIN AVG 5Y
N/A
GROSS MARGIN AVG 10Y
N/A
GROSS MARGIN AVG 15Y
N/A
GROSS MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
42.90%
median of 561 covered companies
CURRENT VS SECTOR MEDIAN
-100.00%
vs the sector median at left
Market Cap
$45.18M
Gross Margin
93.13%
TTM Avg
94.29%
3Y Avg
92.05%
5Y Avg
80.64%
Market Cap
$45.37M
Gross Margin
56.09%
TTM Avg
52.85%
3Y Avg
42.50%
5Y Avg
40.42%
Market Cap
$45.19M
Gross Margin
0.00%
TTM Avg
1.89%
3Y Avg
44.91%
5Y Avg
29.94%
Market Cap
$50.95M
Gross Margin
-262.66%
TTM Avg
-246.22%
3Y Avg
-188.06%
5Y Avg
-150.05%
Market Cap
$51.31M
Gross Margin
100.00%
TTM Avg
100.00%
3Y Avg
100.00%
5Y Avg
100.00%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Lite Strategy, Inc. (LITS) | $47.47M | 0.00% | 0.00% | N/A | N/A |
| Celularity Inc. (CELU)vs › | $48.20M | 79.62% | 74.20% | 42.17% | 48.15% |
| Clene Inc. (CLNN)vs › | $48.94M | 78.50% | 79.02% | 83.51% | 77.08% |
| BioStem Technologies, Inc. (BSEM)vs › | $45.18M | 93.13% | 94.29% | 92.05% | 80.64% |
| DarioHealth Corp. (DRIO)vs › | $45.37M | 56.09% | 52.85% | 42.50% | 40.42% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.19M | 0.00% | 1.89% | 44.91% | 29.94% |
| Envoy Medical, Inc. (COCH)vs › | $50.95M | -262.66% | -246.22% | -188.06% | -150.05% |
| INmune Bio, Inc. (INMB)vs › | $51.31M | 100.00% | 100.00% | 100.00% | 100.00% |
| eXoZymes, Inc. (EXOZ)vs › | $55.97M | 0.00% | 0.00% | 0.00% | 0.00% |
| biote Corp. (BTMD)vs › | $50.28M | 71.46% | 70.99% | 69.42% | 67.35% |
Gross Margin
0.0%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
